A drug-mediated organic electrochemical transistor for robustly reusable biosensors
Ziling Jiang,Dekai Ye,Lanyi Xiang,Zihan He,Xiaojuan Dai,Junfang Yang,Qi Xiong,Yingqiao Ma,Danfeng Zhi,Ye Zou,Qian Peng,Shu Wang,Jia Li,Fengjiao Zhang,Chong-An Di
DOI: https://doi.org/10.1038/s41563-024-01970-5
2024-08-07
Abstract:Reusable point-of-care biosensors offer a cost-effective solution for serial biomarker monitoring, addressing the critical demand for tumour treatments and recurrence diagnosis. However, their realization has been limited by the contradictory requirements of robust reusability and high sensing capability to multiple interactions among transducer surface, sensing probes and target analytes. Here we propose a drug-mediated organic electrochemical transistor as a robust, reusable epidermal growth factor receptor sensor with striking sensitivity and selectivity. By electrostatically adsorbing protonated gefitinib onto poly(3,4-ethylenedioxythiophene):polystyrene sulfonate and leveraging its strong binding to the epidermal growth factor receptor target, the device operates with a unique refresh-in-sensing mechanism. It not only yields an ultralow limit-of-detection concentration down to 5.74 fg ml-1 for epidermal growth factor receptor but, more importantly, also produces an unprecedented regeneration cycle exceeding 200. We further validate the potential of our devices for easy-to-use biomedical applications by creating an 8 × 12 diagnostic drug-mediated organic electrochemical transistor array with excellent uniformity to clinical blood samples.